Home » Topics » Conferences

Conferences
RSS

Efficacy and safety of sublingual apomorphine in treatment of MED

Sep. 7, 1998

Invicorp trial results highlighted at recent congress

Sep. 7, 1998

DMP-695: ACS debut for new, orally active CRF1 antagonist

Sep. 7, 1998

Potent, orally active, second-generation neuroimmunophilin from Guilford

Sep. 7, 1998

Candidate oral fibrinogen receptor antagonist presented by Uriach at ACS meeting

Sep. 7, 1998

Isoxazoline- and isoxazole-containing factor Xa inhibitors prepared by DuPont

Sep. 7, 1998

LLPGE1 evaluated in pilot study; findings will be applied to future studies

Sep. 4, 1998

Alprostadil alfadex is a promising treatment for ED

Sep. 4, 1998

DW-2282: active enantiomer of DW-2143 and potent antitumor agent

Sep. 4, 1998

Merck KGaA synthesizes new PDE V inhibitor with potential for treating ED

Sep. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.